Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chembio Diagnostics Inc (NASDAQ:CEMI)

6.80
Delayed Data
As of 10:11am ET
 -0.05 / -0.73%
Today’s Change
4.03
Today|||52-Week Range
9.40
+27.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$82.4M

Company Description

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its main products presently commercially available are four rapid tests for the detection of HIV antibodies. It sells its products under its STAT PAK, SURE CHECK, DPP and SampleTainer trademarks. The company was founded on May 5, 2004 and is headquartered in Medford, NY.

Contact Information

Chembio Diagnostics, Inc.
3661 Horseblock Road
Medford New York 11763
P:(631) 924-1135
Investor Relations:
16319241135125

Employees

Shareholders

Individual stakeholders9.88%
Mutual fund holders4.66%
Other institutional20.81%

Top Executives

John J. SperzelPresident, Chief Executive Officer & Director
Richard J. LarkinCFO, Principal Financial & Accounting Officer
Javan EsfandiariChief Science & Technology Officer
Sharon KlugewiczPresident-Americas Region
Michael K. SteeleVP-Sales, Marketing & Business Development